Viramal Limited Appoints Experienced Pharmaceutical Executive, Angela Rossetti, To Board Of Directors

NEW YORK--(BUSINESS WIRE)--Viramal, ("the Company"), an emerging specialty pharmaceutical company developing therapeutics that improve the quality of women’s health, today announced the appointment of Angela Rossetti to its Board of Directors, effective immediately.

Ms. Rossetti is a highly qualified corporate director and pharmaceutical executive who brings more than 20 years’ industry experience to Viramal, including 10 years senior-level commercialization expertise at pharmaceutical and biotechnology companies. During the past decade she has been responsible for the commercialization of both mass market and rare disease franchises at Pfizer and Wyeth, and hemophilia products at an early stage biopharmaceutical company, Cell Machines.
MORE ON THIS TOPIC